New polio vaccine shows promise in 1,200 baby trial
NCT ID NCT07297186
First seen Jan 05, 2026 · Last updated Apr 25, 2026 · Updated 19 times
Summary
This study tested a new inactivated polio vaccine made from the Sabin strain in 1,200 healthy infants aged 2 months. The goal was to see if it is safe and triggers a strong immune response against all three types of polio virus. The vaccine is given as a shot, and the results will help protect children from polio.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLIOMYELITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangsu Provincial Center for Diseases Control and Prevention
Nanjing, Jiangsu, 210009, China
Conditions
Explore the condition pages connected to this study.